Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-23

Clinical Trial Update: Antagonist/Letrozole in Poor Responders [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update examining the combination of a GnRH antagonist with letrozole in poor responders undergoing ovarian stimulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GnRH antagonist
  • Letrozole (letrozole)

Snippet

Sponsor: Yazd Research & Clinical Center for Infertility | Conditions: Ovarian Stimulation | Phase 1, Phase 2 | Status: COMPLETED